Bristol Myers Squibb's Latest Data Could Help the Pharma Leapfrog Rival Merck
usx:bmy usx:mrk Blog PostBMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q1 financial results
usx:bmy Blog Post3 Top Healthcare Stocks That Can Make You Richer in 2021 (and Beyond)
usx:veev usx:bmy usx:lly Blog PostExelixis Gets FDA Approval for Cabometyx in Combination Therapy for Front-Line RCC
usx:bmy usx:exel Blog PostInvitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
usx:jnj usx:bmy usx:nvs usx:nvta Blog Post